Delivery Order SPE2DB20D3103-SPE2DB22FN2N4

Award Date 4/5/22
Potential Completion Date 4/6/22
Potential Value $1.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,524.41 firm-fixed-price delivery order is for the supply of 4,562,700 units of Metoprolol Succinate Extended-Release 50 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,976.48 firm fixed-price delivery order is for the supply of Metoprolol Succinate Extended-Release 100 mg tablets. The contract has an ultimate completion date of September 25, 2024 and was awarded on September 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,052.29 firm fixed price delivery order covers the supply of 4,558,966,079 units of the prescription medication Metoprolol Succinate Extended-Release 100 mg tablets. The award has an ultimate completion date of November 3, 2022 and was made on November 2, 2022. This delivery order is part of Amerisourcebergen's...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,498.60 firm fixed-price delivery order is for the supply of 4,566,566,344 units of Metoprolol Succinate Extended-Release 100 mg tablets. The contract has an ultimate completion date of November 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.13 Firm Fixed Price Delivery Order is for the supply of 4567171084 Metoprolol Succinate ER 100 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,255.46 firm fixed-price delivery order is for 4,564,098,481 units of the medication Metoprolol Succinate Extended-Release 25 mg tablets, with an ultimate completion date of March 28, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $2,507.33, is for the delivery of Metoprolol Succinate Extended-Release 100 mg tablets in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of September 28, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Metoprolol Succinate Extended-Release 50mg tablets in 1,000 count packages. The $1,938.50 fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,017.56 firm fixed-price delivery order is for the supply of 4,566,209,977 units of Metoprolol Succinate Extended-Release 50mg Tablets. The contract has an ultimate completion date of October 28, 2024. This award is not designated as a set-aside contract. The contract is associated with a larger Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 4,565,802,734 units of Metoprolol Succinate Extended-Release 100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,308.84 and a period of performance through September 16, 2024. AmerisourceBergen, a for-profit organization, is not subject to any set-aside requirements for this award. The company...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FN2N4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,706.13 firm fixed price delivery order is for the supply of Metoprolol Succinate Extended-Release 100 mg tablets in quantities of 1,000.

The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

In addition to the DLA contract, Cencora, Inc. also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:12 AM